Could this drug be the next Ozempic? Lilly reports dramatic trial results
Eli Lilly says its experimental drug retatrutide delivered more than double the weight loss of Ozempic in a Phase 3 diabetes trial.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by KGTV ABC 10 San Diego; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories
Why it mattersOcean water levels along the California coast are reaching some of their highest readings in more than a century, with massive underwater waves linked to El Niño contributing to the unusually high seas, federal officials…
Ocean water levels along the California coast are reaching some of their highest readings in more than a century, with massive underwater waves linked to El Niñ…
By Chella·1h ago
Why it mattersThe treatments have been promoted online by wellness influencers.
By Chella·41m ago
Why it mattersThe NYPD says it has seized 4,500 illegal guns so far in 2026. Officials say 100 fewer people have been shot compared with this time last year.
By Chella·1h ago
Why it mattersBarack Obama’s Cleveland campaign speech mixed endorsements of Amy Acton and Sherrod Brown with criticism of Republicans, his own party and a broader message about AI and voter responsibility.
By Chella·1h ago